CimaVax-EGF

CimaVax-EGF is the first therapeutic cancer vaccine developed to target lung cancer. The vaccine was the result of a 25-year research project at Cuba’s Center of Molecular Immunology.[1]

References

  1. ^ "Cuba Announces Release of the World's First Lung Cancer Vaccine". PopSci. 2011-08-09. http://www.popsci.com/science/article/2011-09/cuba-releases-worlds-first-lung-cancer-vaccine. Retrieved 2011-12-11.